Abstract
Background
Shortages of health workers and large number of HIV-infected persons in Africa mean that time to provide antiretroviral therapy (ART) adherence and other messages to patients is limited.
Methods
Using time-motion methodology we documented the intensity and nature of counseling delivered to patients. The study was conducted at a rural and an urban HIV clinic in western Kenya. We recorded all activities of 190 adult patients on ART during their return clinic visits to assess type, frequency, and duration of counseling messages.
Results
Mean visit length for patients at the rural clinic was 44.5 (SD=27.9) minutes and at urban clinic was 78.2 (SD=42.1) minutes. Median time spent receiving any counseling during a visit was 4.07 minutes (IQR 1.57–7.33) at rural and 3.99 (IQR 2.87–6.25) minutes at urban, representing 11% and 8% of total mean visit time respectively. Median time patients received ART adherence counseling was 1.29 (IQR 0.77–2.83) minutes at rural and 1.76 (IQR 1.23–2.83) minutes at urban (p=0.001 for difference). Patients received a median of 0.18 (0–0.72) minutes at rural and 0.28 (IQR 0–0.67) minutes at urban clinic of counseling regarding contraception and pregnancy. Most patients in the study did not receive any counseling regarding alcohol/substance use, emerging risks for ongoing HIV transmission.
Conclusions
Though ART adherence was discussed with most patients, time was limited. Reproductive counseling was provided to only half of patients, and ‘positive prevention’ messaging was minimal. There are strategic opportunities to enhance counseling and information received by clients within HIV programs in resource-limited settings.
Keywords: HIV, time-motion, counseling messages, antiretroviral therapy, sub-Saharan Africa, clinic services
INTRODUCTION
Over seventy percent of the estimated 35 million people living with HIV/AIDS globally reside in sub-Saharan Africa,1 yet the region contains only three percent of the world’s health care workers. With funding through PEPFAR and other sources, Kenya has gone from essentially treating no patients in need of antiretroviral therapy (ART) in 2003 to an estimated 73 percent coverage by the end of 2012.2 Patients receiving care present an opportunity for HIV prevention. Patients who are non-adherent to their antiretroviral regimens are at risk of developing resistant virus, increased viral load, and pose a threat of transmitting resistant virus. If patients are engaged with the health care system, they can be reached for ART adherence counseling, receive secondary HIV prevention messages and information on strategies to support healthy behaviors. However, given the shortage of health care workers in Africa, the necessary scale-up of ART has placed a strain on health care systems.3,4 Consequently, the time that health care workers have to provide HIV counseling messages and patient education is limited.
Antiretroviral treatment as a means of preventing new infections has been clearly demonstrated.5,6 As such, ‘treatment as prevention’ adds to the armamentarium of interventions to reduce HIV transmission that currently includes risk reduction, barrier methods, pre-exposure prophylaxis, male circumcision, prevention of mother to child transmission of HIV (Option B+)7 and post-exposure prophylaxis.8–14 Prevention scientists have embraced the need for combination approaches for the mitigation of ongoing HIV transmission with the inclusion of jurisdiction-specific strategies implemented in concert.15–18 However, use of strategies such as treatment as prevention and barrier methods require high adherence on an ongoing basis to achieve and maintain effectiveness. Counseling and other psychosocial interventions designed to engender behavioral risk modification and maintenance have been widely studied.19–26 However, the uptake and intensity of these activities within HIV care and treatment programs in sub-Saharan Africa remains uncertain.
In this study, we used time-motion methodology to assess frequency and types of counseling and adherence messages during return clinic visits for adult HIV-positive patients receiving ART. The time-motion methodology is a technique for collecting activity information, where an observer records exact activities and time it takes for tasks to be done by the subject.27 Time-motion methodology is usually regarded as being the most reliable compared to alternative methods such as work sampling and time efficiency questionnaires.28
Our aims were to: (1) identify the types of counseling and ART adherence messages given to patients during these visits; (2) determine the amount of time spent on counseling; (3) identify unmet counseling needs; and (4) determine other times during a routine clinic visit where alternative counseling strategies (that do not depend on a clinician) could be introduced.
METHODS
Study Design
To assess frequency of counseling and adherence messages given to patients during clinic visits, we recorded all activities by patients for the full length of their clinic visits. Recorded activities included the types of counseling – such as ‘positive prevention’ messages supporting safer sexual behaviors – the patient received during the visit and the length of time over which the messages were given. These observations were done using time-motion methodologies that we have previously employed in Kenya29 and Uganda.30,31
Population
For this study we observed adult HIV-positive patients on ART coming for return clinical visits. We excluded patients not on ART, patients who were HIV negative, and patients less than 18 years of age. We followed a convenience sample of 100 established HIV-positive adult patients presenting for routine visits at each of the two study clinics. This number was based on our prior experience conducted for similar time motion studies.30 Patients were contacted by trained research assistants (RAs) as soon as they entered the clinic for the visit. All patients who expressed interest in hearing more about the study received a detailed explanation about the nature of the study. They were made aware that they would be followed and observed by an RA throughout the clinic visit. Only those patients who provided written consent were included in the study. All providers working at the two study clinics were also informed and educated about the nature of the study by the study coordinator. All providers who agreed to be observed provided verbal consent prior to the beginning of the study. Patient data from ten observations were excluded because of incomplete/inadequate collection, resulting in available observations for 190 patients.
Setting
This study was conducted between February 10 and March 16, 2010 at two HIV clinics affiliated with the Academic Model Providing Access to Healthcare (AMPATH) program in western Kenya32. This program provided comprehensive care at the time of the study to more than 85,000 active HIV-positive patients through 35 parent and 26 satellite clinics (Figure 1); the patient census is now 140,000. The two clinics in this study included one urban AMPATH clinic located in Eldoret, Kenya (Module 1 or M1) and a second rural clinic in Burnt Forest, Kenya (BF). The characteristics of these clinics at the end of the study period are outlined in Table 1. Tuberculosis (TB) and HIV services are significantly more integrated at M1 than at BF. At the M1 urban clinic TB medications are prescribed and dispensed in a separate TB clinic whereas in the rural BF setting TB care for the majority of patients is provided within the HIV clinic. M1 also has a reproductive health program that provides some modern birth control methods (pills, Depo-Provera and condoms) and counseling about family planning as well as perinatal visits. Both clinics had access to client support groups though no other specific educational efforts were available or ongoing in waiting rooms at the time of this study. Approximately 90 percent of patient visits at the study clinics are conducted by nurses and clinical officers (equivalent to nurse practitioners or physician assistants) without the presence of a supervising physician. Consulting physicians are available on specified clinic days to address patients with complex clinical problems such as those with severe adverse events, major opportunistic infections or those failing treatment. The consulting physicians are also available by phone as needed.
Table 1.
Clinic Characteristics | Rural Clinic (BF) | Urban Clinic (M1) |
---|---|---|
Primary Affiliation(s) | USAID-AMPATHa | USAID-AMPATHa |
Location type | Resource-poor rural setting | Resource-poor urban setting |
Adult HIV+ patients in care | 2,563 | 6,750 |
Adult Patients on ARVsb | 1024 | 2,694 |
Average daily patient census | 119 (SD 34, range 71 – 197) | 107 (SD 45, range 62 – 172) |
Number of full-time physiciansc | 0.01 | 0.02 |
Number of full-time COsd | 4 | 8 |
Number of full-time Nurses | 3 | 8 |
USAID-AMPATH - United States Agency for International Development - Academic Model Providing Access to Healthcare
ARVs – Antiretroviral HIV medication
Represents full-time equivalent (FTE) effort
CO – Clinical Officers (equivalent to nurse practitioners/physician assistants)
Data Collection
We programmed a list of patient activities into Personal Digital Assistant (PDA) devices using the HanDBase® software (DDH Software, Inc., Wellington, Florida)(See Table 3). These PDAs were used by five trained RAs, also known as observers, to monitor patient activities during the patient’s clinic visit. All RAs were trained on how to use the PDAs and software, as well as about study specifics and the content of the pre-established list of activities in the structured menu. All RAs were given consistent definitions for all activities [see Table 3]. In addition, all RAs were trained in human subject protection and study protocol to ensure the privacy of study participants and safety of the data.
Table 3.
Event | Analysis Group |
---|---|
Registration: Getting Registered | Registration |
START: PT ENTERING CLINIC | START |
Waiting/Walking (to doctor/nurse/pharmacist/peer Doctor/Nurse/Pharmacist/Peer/Other: |
Waiting/Walking |
Question: ART Adherence | ART Adherence Question |
Question: Risky Behavior | Risky Behavior Question |
‘Abstinence, Be Faithful, Condoms’ | Positive Prevention Messages |
Alcohol & Drug Use | Alcohol & Drug Use |
Alternative/Herbal Meds Use | ART Adherence Message |
ART Adherence | ART Adherence Message |
Contraception & Pregnancy | Contraception & Pregnancy |
Disclosure | Disclosure |
Health Promotion Plan | Health Promotion Plan |
Referral to Other Counselor | Referral |
Risky Behavior & Change | Positive Prevention Messages |
Other Counseling | Other Counseling |
Patient Other Time with Provider | Patient Other Time with Provider |
Patient Personal Time | Patient Personal Time |
END: PATIENT DONE WITH CLINIC VISIT | END |
When study patients arrived at the clinic for the visit,, the RA opened a HanDBase visit record in the PDA. When the subject initiated the first observed activity (such as talking), the observer initiated an observation record in the PDA, which assigned a beginning time to the activity. Once it became clear to the observer what the activity was, he or she recorded the activity by picking it from the pre-established list in a structured menu. When the next activity began, the observer entered a new observation into the PDA, which assigned an ending time to the previous activity and a beginning time to the next activity. “Down time” or inactivity by patient was recorded as “waiting.” No conversation was allowed between the person being observed and the RA once the observations were in progress.
The observer recorded all activities until the patient was formally done with the clinic visit (i.e., until the patient left the clinic setting). The RA would contact the first patient who was entering the clinic at the beginning of the RA’s shift. Once they were done observing this patient, they could pick the next patient entering the clinic for the next observation. This continued until the end of the clinic day, at which time the research assistants transferred the data collected in the PDAs to a Microsoft-Access® database (Microsoft Corp, Redmond, WA).
Data Analysis
The unit of analysis for patients was the clinic visit, which was defined as the time from patient’s registration to the time he or she checked-out of the clinic. We excluded from the main analysis all wait times before a patient’s clinic registration/check-in because there is wide variability in the time at which some patients present before clinics open (there being no strict appointment scheduling system at either site).
In our analyses, we assessed the frequency with which ART adherence and risk behavior questions were asked during visits. We also determined the frequency with which counseling was provided on: alcohol and drug use, contraception/pregnancy, disclosure, and positive prevention messages. The amount of time per visit spent on each of these counseling categories was assessed. Times spent by patients waiting for care also were computed to help determine other possible times during the clinic visits where other forms of counseling that do not depend on a clinical provider could be delivered to patients. Median counseling time was calculated and stratified by content of counseling (adherence, family planning/risk reduction, alcohol and substance abuse, disclosure and other types [positive prevention messages, health promotion plans, unspecified]), and by clinic. Counseling times were compared between clinics using Wilcoxon rank sum tests.
RESULTS
During the study period, a mean of 38 (SD = 18, range 6–71) patients visited BF each clinic day, while 97 (SD 21, range 69–133) visited M1. We made full-visit observations for 96 patients at BF and 94 at M1 for a total of 194 hours of patient observations. The mean visit length for patients at BF was 44.5 (SD=27.9) minutes and at M1 was 78.2 (SD=42.1) minutes.
The median time spent receiving or participating in any counseling during a clinic visit was 4.07 minutes (IQR 1.57–7.33) at BF and 3.99 (IQR 2.87–6.25) minutes at M1, representing 11% and 8% of total mean visit time respectively (Table 2; Figure 2). Median (IQR) of total waiting times at each clinic were 21 (12–39) minutes at BF and 56 (31–77) minutes at M1. This represented 66% and 78% of total visit times respectively at the two sites (Figure 2).
Table 2.
Category | BF (N = 96) | Mod 1 (N = 94) | p value |
---|---|---|---|
ART adherence | 1.29 (0.77–2.55) | 1.76 (1.23–2.83) | 0.001 |
Alcohol and drug use | 0 (0–1.52) | 0 (0–0.12) | 0.001 |
Family planning and behavioral risk reduction | 0.18 (0–0.72) | 0.28 (0–0.67) | 0.39 |
Disclosure | 0.18 (0–1.21) | 0.18 (0–0.42) | 0.81 |
Other† | 0.50 (0.24–1.25) | 1.07 (0.42–1.77) | 0.004 |
Total | 4.07 (1.57–7.33) | 3.99 (2.87–6.25 | 0.23 |
included positive prevention messages, health promotion plans and non-categorized counseling
Values in parentheses represent IQR for time in minutes
The number of patients who received any counseling during their visit on specific issues related to HIV harm reduction, and/or care and treatment was as follows (Table 2): alcohol and drug use overall n=62 (33%) [(38, 40%) for BF and (24, 26%) for M1]; ART adherence overall n=188 (99%)[(95, 99%) for BF1 and (94,99%) for M1]; contraception/pregnancy overall n=95 (50%) [(39, 41%) for BF and (56, 60%) for M1]; disclosure overall n= 121(64%) [(54, 56%) for BF and (67, 71%) for M1]; and positive prevention messages overall n= 129, (68%) [(48,50%) for BF and (81,86%) for M1]. The median time patients received counseling related to antiretroviral adherence was 1.29 (IQR 0.77–2.83) minutes at BF and 1.76 (IQR 1.23–2.83) minutes at M1 (Table 2; p=0.001 for difference). This content area comprised 25% and 30% of the total mean counseling delivered per visit on average at each site respectively. Patients received a median of 0.18 (0–0.72) minutes at BF and 0.28 (IQR 0–0.67) minutes at M1 of counseling regarding contraception, family planning and pregnancy combined (p=0.39 for difference). Staff-delivered positive-prevention messages averaged 17 and 39 seconds at the respective clinics (data not shown). Most (n=174, 92%) patients were specifically asked by a provider about their adherence to ART while fewer (n=57, 30%) were asked about risky behaviors during their visit.
DISCUSSION
This study documented high rates of ART adherence counseling being delivered within busy HIV care and treatment clinics in a resource-limited setting. Nearly all of the patients observed in this study (99%) were asked about their adherence to ART during the period since their prior clinic visit and were supplied with messaging and support to continue and/or strengthen their medication adherence. Fewer patients received counseling in other content areas relevant to HIV treatment and prevention, including harm reduction behaviors to keep sexual partners healthy and contraception for family planning, despite an integrated approach to reproductive health instituted at one of the clinics studied (M1). Furthermore, only limited counseling was provided with regards to alcohol and drug use within these two settings. This is of concern given the increasing understanding of the hazardous role alcohol use may play in HIV adherence, outcomes and transmission.33–35
Despite the focus of clinicians and health care workers on adherence messaging and counseling in these two clinics, on average less than two minutes were spent with each patient discussing this critical issue. Moreover, on average patients spent approximately 5–6 minutes (8–11%) during their clinic visit involved in counseling discussions with health care professionals, while spending between 30–60 minutes (66%–78%) waiting during their visit. Only very limited counseling on family planning and behavioral harm reduction was observed in this setting.
These findings are consistent with prior time-motion studies conducted in East African HIV care and treatment settings. Were, et al. found that in two Ugandan HIV continuity clinics between 62–66% of patient visit time was spent waiting.30 Some prior studies have found gaps in the quality of HIV-related care within programmatic settings in sub-Saharan Africa, including inadequate focus on reproductive health needs and adherence messaging.36–38 However, we believe this is the first study to specifically quantify the magnitude and content of counseling received within ART programs in this setting.
There is limited evidence to inform health care providers and decision makers on the correct “dose” of counseling needed to improve a variety of critical behaviors related to HIV disease progression and transmission including adherence to ART, sexual risk reduction, or family planning strategies. One prior study amongst HIV-infected drug users in an industrialized setting found a 20% increase in ART adherence for every additional hour of counseling received.39 In addition, clinic attendance and the presence of adherence support services within a HIV care and treatment program have been shown to improve clinical outcomes.40,41 While a majority of patients in this study received at least some counseling each visit, it remains uncertain as to whether this was sufficient to affect significant behavior modification or alteration.
Our study suggests that opportunities exist to maximize how HIV-positive patients spend their time during a clinic visit. In particular, there is great opportunity to use this time to engender critical behavior change or maintenance amongst HIV-infected persons. Approaches that could be used include group-based information and counseling sessions, use of expert patients and community health workers to provide counseling during the time patients are waiting. Computer-based or electronic health based delivery mechanisms may be one important methodology in need of further study in this region as it requires fewer additional human resources and offers consistency of messaging. Early studies amongst HIV-infected persons suggest that it may be efficacious; clinic-based computer delivered interventions have been shown to improve adherence among patients with baseline adherence that is less than 95%.21,42
There are several limitations in this study that may have biased our findings or limit their generalizability. First, observing the patients and providers may have changed their behavior (i.e., Hawthorne effect) potentially resulting in an overestimation of the amount and magnitude of counseling received by clients in these clinics. Secondly, there may have been selection bias secondary to the sampling methodology. Third, the observations took place in only two clinics within one care and treatment program (AMPATH). In addition, beyond applying strict exclusion criteria, detailed demographic information was not collected, and these data could potentially have impacted some interpretation of the findings. Finally, this study evaluated the frequency and types of counseling messages delivered to HIV patients, but we did not assess the quality or specifics of the messages delivered.
Through this study, we were able to demonstrate the nature of, and opportunity to improve, counseling messages for HIV-positive patients visiting clinics in resource-limited settings in sub-Saharan Africa. There is substantial room to improve on the type, duration, and quality of counseling messages provided. Innovative approaches using media and technology could help fill the human-capacity gap by offering counseling mechanisms especially during the extended waiting periods in a patient’s visit. Notable strengths of this study include the evaluation in two different clinic settings, both urban and rural, as well as attempting to assess not only the quantity of counseling delivered and received in these setting but an understanding of the focus and content areas that were addressed.
CONCLUSION
In these sampled clinics there were relatively high rates, but limited amounts of time, spent by providers on counseling. We identified significant amounts of wait time that could potentially be used for self-administered patient education and counseling. Though adherence was discussed with almost all HIV-positive patients on ARVs during their clinic visit, the time committed to adherence counseling was minimal (small or limited). Positive prevention messaging was not consistently or extensively delivered. Most patients in the study did not receive any counseling regarding alcohol and substance use, an emerging risk factor in the ongoing transmission of HIV in this setting. There are ample existing opportunities to improve upon and enhance the quantity of the counseling received within HIV care and treatment programs. Greater efficiency and impact in these settings may result in fewer new HIV infections and improved life expectancy and quality for those living with HIV.
Acknowledgments
We thank the following deeply for their contributions and support: our research assistants at Moi University School of Medicine for performing the patient observations.
Source of Funding: The National Institutes of Health (NIH): R01MH085577 (Kurth) provided financial support for this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
Footnotes
Conflict of Interest: All authors report no conflict of interest.
AUTHORS’ CONTRIBUTIONS
Dr. Kurth had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Principal Investigators: Kurth and Siika
Study concept and design: Kurth, Siika, Sidle, Were
Intervention content: Kurth
Acquisition of data: Macharia
Analysis and interpretation of data: Shen, Were, Wools-Kaloustian
Statistical analysis: Shen
Drafting of the manuscript: Kurth, Were, Wools-Kaloustian, Kessler, Lizcano
Critical revision of the manuscript for important intellectual content: All authors.
References
- 1.Wei X, Zheng K, Chen M, et al. Transcription analysis of lignocellulolytic enzymes of Penicillium decumbens 114–2 and its catabolite-repression-resistant mutant. Comptes rendus biologies. 2011 Nov;334(11):806–811. doi: 10.1016/j.crvi.2011.06.002. [DOI] [PubMed] [Google Scholar]
- 2.Organization WH. Global update on HIV treatment 2013: results, impact and opportunities. Geneva: World Health Organization; 2013. [Google Scholar]
- 3.Anyangwe SC, Mtonga C. Inequities in the global health workforce: the greatest impediment to health in sub-Saharan Africa. International journal of environmental research and public health. 2007 Jun;4(2):93–100. doi: 10.3390/ijerph2007040002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Zachariah R, Ford N, Philips M, et al. Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009 Jun;103(6):549–558. doi: 10.1016/j.trstmh.2008.09.019. [DOI] [PubMed] [Google Scholar]
- 5.Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. The Lancet. 375(9731):2092–2098. doi: 10.1016/S0140-6736(10)60705-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11;365(6):493–505. doi: 10.1056/NEJMoa1105243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Organization WH. Programmatic Update Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Executive Summary. 2012 http://www.who.int/hiv/PMTCT_update.pdf. Accessed Februry, 2015.
- 8.Creese A, Floyd K, Alban A, Guinness L. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. The Lancet. 2002;359(9318):1635–1642. doi: 10.1016/S0140-6736(02)08595-1. [DOI] [PubMed] [Google Scholar]
- 9.Galarraga O, Colchero MA, Wamai RG, Bertozzi SM. HIV prevention cost-effectiveness: a systematic review. BMC Public Health. 2009;9(Suppl 1):S5. doi: 10.1186/1471-2458-9-S1-S5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hogan DR. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. Bmj. 2005;331(7530):1431–1437. doi: 10.1136/bmj.38643.368692.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Charania MR, Crepaz N, Guenther-Gray C, et al. Efficacy of structural-level condom distribution interventions: a meta-analysis of U.S. and international studies, 1998–2007. AIDS Behav. 2011 Oct;15(7):1283–1297. doi: 10.1007/s10461-010-9812-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gray RH, L X, Kigozi G, et al. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. Aids. 2007;21:845–850. doi: 10.1097/QAD.0b013e3280187544. [DOI] [PubMed] [Google Scholar]
- 13.Hsu J, Zinsou C, Parkhurst J, N’Dour M, Foyet L, Mueller DH. Comparative costs and cost-effectiveness of behavioural interventions as part of HIV prevention strategies. Health Policy Plan. 2013 Jan;28(1):20–29. doi: 10.1093/heapol/czs021. [DOI] [PubMed] [Google Scholar]
- 14.Schackman BR, Eggman AA. Cost-effectiveness of pre-exposure prophylaxis for HIV: a review. Curr Opin HIV AIDS. 2012 Nov;7(6):587–592. doi: 10.1097/COH.0b013e3283582c8b. [DOI] [PubMed] [Google Scholar]
- 15.Bekker LG, Beyrer C, Quinn TC. Behavioral and biomedical combination strategies for HIV prevention. Cold Spring Harbor perspectives in medicine. 2012;2(8) doi: 10.1101/cshperspect.a007435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV prevention: significance, challenges, and opportunities. Current HIV/AIDS reports. 2011 Mar;8(1):62–72. doi: 10.1007/s11904-010-0063-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Marrazzo JM, Cates W. Interventions to prevent sexually transmitted infections, including HIV infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011 Dec;53(Suppl 3):S64–78. doi: 10.1093/cid/cir695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Rotheram-Borus MJ, Swendeman D, Chovnick G. The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annual review of clinical psychology. 2009;5:143–167. doi: 10.1146/annurev.clinpsy.032408.153530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Barnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. The Lancet infectious diseases. 2011 Dec;11(12):942–951. doi: 10.1016/S1473-3099(11)70181-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Chung MH, Richardson BA, Tapia K, et al. A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes. PLoS medicine. 2011 Mar;8(3):e1000422. doi: 10.1371/journal.pmed.1000422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Fisher JD, Amico KR, Fisher WA, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS and behavior. 2011 Nov;15(8):1635–1646. doi: 10.1007/s10461-011-9926-x. [DOI] [PubMed] [Google Scholar]
- 22.Golin CE, Earp J, Tien HC, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. Journal of acquired immune deficiency syndromes (1999) 2006 May;42(1):42–51. doi: 10.1097/01.qai.0000219771.97303.0a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Topics in HIV medicine: a publication of the International AIDS Society, USA. 2009 Feb-Mar;17(1):14–25. [PMC free article] [PubMed] [Google Scholar]
- 24.Remien RH, Mellins CA, Robbins RN, et al. Masivukeni: development of a multimedia based antiretroviral therapy adherence intervention for counselors and patients in South Africa. AIDS and behavior. 2013 Jul;17(6):1979–1991. doi: 10.1007/s10461-013-0438-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Lopez LM, Hilgenberg D, Chen M, Denison J, Stuart G. Behavioral interventions for improving contraceptive use among women living with HIV. The Cochrane database of systematic reviews. 2013;1:CD010243. doi: 10.1002/14651858.CD010243.pub2. [DOI] [PubMed] [Google Scholar]
- 26.Townsend L, Mathews C, Zembe Y. A systematic review of behavioral interventions to prevent HIV infection and transmission among heterosexual, adult men in low-and middle-income countries. Prevention science: the official journal of the Society for Prevention Research. 2013 Feb;14(1):88–105. doi: 10.1007/s11121-012-0300-7. [DOI] [PubMed] [Google Scholar]
- 27.Finkler SA, Knickman JR, Hendrickson G, Lipkin M, Jr, Thompson WG. A comparison of work-sampling and time-and-motion techniques for studies in health services research. Health services research. 1993 Dec;28(5):577–597. [PMC free article] [PubMed] [Google Scholar]
- 28.Zheng K, Guo MH, Hanauer DA. Using the time and motion method to study clinical work processes and workflow: methodological inconsistencies and a call for standardized research. Journal of the American Medical Informatics Association: JAMIA. 2011 Sep-Oct;18(5):704–710. doi: 10.1136/amiajnl-2011-000083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Rotich JK, Hannan TJ, Smith FE, et al. Installing and implementing a computer-based patient record system in sub-Saharan Africa: the Mosoriot Medical Record System. J Am Med Inform Assoc. 2003 Jul-Aug;10(4):295–303. doi: 10.1197/jamia.M1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Were MC, Sutherland JM, Bwana M, Ssali J, Emenyonu N, Tierney WM. Patterns of care in two HIV continuity clinics in Uganda, Africa: a time-motion study. AIDS care. 2008 Jul;20(6):677–682. doi: 10.1080/09540120701687067. [DOI] [PubMed] [Google Scholar]
- 31.Were MC, Shen C, Bwana M, et al. Creation and evaluation of EMR-based paper clinical summaries to support HIV-care in Uganda, Africa. International journal of medical informatics. 2010 Feb;79(2):90–96. doi: 10.1016/j.ijmedinf.2009.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Einterz RM, Kimaiyo S, Mengech HN, et al. Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med. 2007;82(8):812–818. doi: 10.1097/ACM.0b013e3180cc29f1. [DOI] [PubMed] [Google Scholar]
- 33.Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010 Dec 1;112(3):178–193. doi: 10.1016/j.drugalcdep.2010.06.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kalichman SC, Simbayi LC, Kaufman M, Cain D, Jooste S. Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: systematic review of empirical findings. Prev Sci. 2007 Jun;8(2):141–151. doi: 10.1007/s11121-006-0061-2. [DOI] [PubMed] [Google Scholar]
- 35.Shuper PA, Neuman M, Kanteres F, Baliunas D, Joharchi N, Rehm J. Causal considerations on alcohol and HIV/AIDS–a systematic review. Alcohol Alcohol. 2010 Mar-Apr;45(2):159–166. doi: 10.1093/alcalc/agp091. [DOI] [PubMed] [Google Scholar]
- 36.Scott V, Zweigenthal V, Jennings K. Between HIV diagnosis and initiation of antiretroviral therapy: assessing the effectiveness of care for people living with HIV in the public primary care service in Cape Town, South Africa. Tropical medicine & international health: TM & IH. 2011 Nov;16(11):1384–1391. doi: 10.1111/j.1365-3156.2011.02842.x. [DOI] [PubMed] [Google Scholar]
- 37.Kinkel HF, Adelekan AM, Marcus TS, Wolvaardt G. Assessment of service quality of public antiretroviral treatment (ART) clinics in South Africa: a cross-sectional study. BMC health services research. 2012;12:228. doi: 10.1186/1472-6963-12-228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Myer L, Rebe K, Morroni C. Missed opportunities to address reproductive health care needs among HIV-infected women in antiretroviral therapy programmes. Tropical medicine & international health: TM & IH. 2007 Dec;12(12):1484–1489. doi: 10.1111/j.1365-3156.2007.01955.x. [DOI] [PubMed] [Google Scholar]
- 39.Cooperman NA, Heo M, Berg KM, et al. Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users. AIDS care. 2012;24(7):828–835. doi: 10.1080/09540121.2011.644231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Brennan AT, Maskew M, Sanne I, Fox MP. The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa. Journal of the International AIDS Society. 2010;13:49. doi: 10.1186/1758-2652-13-49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Lamb MR, El-Sadr WM, Geng E, Nash D. Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa. PloS one. 2012;7(6):e38443. doi: 10.1371/journal.pone.0038443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ownby RL, Waldrop-Valverde D, Caballero J, Jacobs RJ. Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence. Neurobehavioral HIV medicine. 2012 Oct 18;4:113–121. doi: 10.2147/NBHIV.S36549. [DOI] [PMC free article] [PubMed] [Google Scholar]